losartan and atrial natriuretic factor

losartan has been researched along with atrial natriuretic factor in 61 studies

Research

Studies (61)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	24 (39.34)	18.2507
2000's	21 (34.43)	29.6817
2010's	16 (26.23)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kuramochi, M	1
Garcia, R; Qing, G	1
Mao, L; Rockman, HA; Ross, J; Wachhorst, SP	1
Fukui, T; Horio, T; Kohno, M; Kurihara, N; Takeda, T; Yasunari, K; Yokokawa, K; Yoshiyama, M	1
Everett, AD; Fisher, A; Gomez, RA; Tufro-McReddie, A	1
Abassi, ZA; Golomb, E; Keiser, HR; Kelly, G; Klein, H	1
Mimran, A; Nafrialdi, N; Ribstein, J; Valentin, JP	1
Barthélemy, C; Carayon, A; Maistre, G; Masson, F; Soualmia, H	1
Gorczynska, E; Handelsman, DJ; Spaliviero, J	1
Gambaryan, S; Haase, W; Häusler, C; Jarchau, T; Kurtz, A; Lohmann, SM; Markert, T; Pöhler, D; Walter, U	1
Barreto-Chaves, ML; Mello-Aires, M	1
Leskinen, H; Ruskoaho, H; Vuolteenaho, O	1
Chong, CK; Honrath, U; Sonnenberg, H; Veress, AT	1
Dickstein, K; Hall, C; Klinge, R; Polis, A	1
Hertenberg, F; Smits, P; Vervoort, G; Wetzels, JF	1
Böhm, M; Buikema, H; Flesch, M; Paul, M; Pinto, YM; Teisman, AC; van Gilst, WH	1
Flapan, AD; Goodfield, NE; Ludlam, CA; Newby, DE	1
Ackermann, U; Chong, CK; Melo, LG; Sonnenberg, H; Veress, AT	1
Coviello, A; Peral de Bruno, M; Romano, L	1
Kähönen, M; Kalliovalkama, J; Magga, J; Pörsti, I; Romppanen, H; Ruskoaho, H; Tolvanen, JP; Vuolteenaho, O	1
Dali-Youcef, N; Nemer, M; Paradis, FW; Paradis, P; Thibault, G	1
De Paolis, P; Gigante, B; Panina, G; Piras, O; Rubattu, S; Savoia, C; Volpe, M	1
Ackermann, U; Azizi, N	1
Fu, M; Liu, N; Pang, Y; Su, J; Tang, C; Xu, S; Zhang, J	1
Cowley, AJ; Harrison, M; Houghton, AR	1
De Mello-Aires, M; Oliveira-Souza, M	1
Bahlmann, L; Heringlake, M; Klaus, S; Pagel, H; Schmucker, P; Wagner, K	1
Demura, M; Mabuchi, H; Takeda, Y; Usukura, M; Yoneda, T	1
Hirose, N; Kinoshita, M; Koga, A; Matsuki, H; Miki, K; Ogawa, M; Ogimoto, M; Saku, K	1
Bonhomme, MC; Diebold, S; Garcia, R	1
Jolma, P; Kalliovalkama, J; Pörsti, I; Ruskoaho, H; Suo, M; Tolvanen, JP; Vuolteenaho, O	1
Fukuda, N; Onose, Y; Sakabe, K; Shinohara, H; Soeki, T; Tamura, Y	1
Fan, M; Jolma, P; Kähönen, M; Kalliovalkama, J; Kööbi, P; Pörsti, I; Ruskoaho, H; Rysä, J; Tikkanen, I; Vuolteenaho, O; Ylitalo, P	1
deChâtel, R; Földes, G; Ilves, M; Lakó-Futó, Z; Leskinen, H; Ruskoaho, H; Sármán, B; Skoumal, R; Szokodi, I; Tokola, H; Tóth, M; Vuolteenaho, O	1
Berezin, AE; Vizir, VA	1
Charles, CJ; Espiner, EA; Frampton, CM; Nicholls, MG; Rademaker, MT; Richards, AM	1
Barbella, Y; Israel, A; Zavala, L	1
Desjardins, JF; Lapointe, N; Nguyen, QT; Parker, TG; Pourdjabbar, A; Rouleau, JL; Tsoporis, JN	1
Bang, LE; Devereux, RB; Fossum, E; Hall, C; Hildebrandt, PR; Ibsen, H; Olsen, MH; Rokkedal, J; Tuxen, C; Wachtell, K	1
Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E	1
Dahlöf, B; Devereux, RB	1
Frank, K; Müller-Ehmsen, J; Rana, OR; Reuter, H; Saygili, E; Schwinger, RH; Zobel, C	1
Carstens, J; Pedersen, EB	1
Ferrario, CM; Gallagher, PE; Tallant, EA	1
Djøseland, O; Hall, C; Karlberg, BE; Klinge, R	1
Kang, BY; Khan, JA; Mehta, JL; Ryu, S; Seung, KB; Shekhar, R	1
Ge, J; Gong, H; Komuro, I; Li, L; Lin, L; Wu, J; Zhou, N; Zou, Y	1
Gao, S; Kim, JH; Kim, SH; Oh, YB; Park, WH; Shah, A	1
Gao, S; Kim, HT; Kim, SH; Lim, JM; Oh, YB; Park, BH	1
Cannon, MV; de Boer, RA; Mahmud, H; Meems, LM; Ruifrok, WP; Silljé, HH; van Gilst, WH; Voors, AA	1
Cha, SA; Gao, S; Kang, KP; Kim, SH; Oh, YB; Park, BM	1
Adem, A; Al Haj, M; Benedict, S; Frampton, CM; Kazzam, E; Lewis, LK; Nagelkerke, N; Nicholls, MG; Nyberg, F; Yandle, TG; Yasin, J	1
Cha, SA; Gao, S; Kim, SH; Park, BH; Park, BM; Park, WH	1
Antunes-Rodrigues, J; Araujo, IG; Elias, LL; Mecawi, AS; Reis, LC	1
Cha, SA; Han, BR; Kim, SH; Park, BM	1
Korostyshevskaya, IM; Maksimov, VF; Markel', AL; Rudenko, NS; Yakobson, GS	1
Iakobson, GS; Korostyshevskaia, IM; Kurganov, SA; Maksimov, VF; Markel', AL; Rudenko, NS	1
Della Penna, SL; Fernández, BE; Rosón, MI; Toblli, JE	1
Chen, XH; Ding, YY; Li, JM; Liu, Y; Lu, XL; Pan, XC; Tong, YF; Wang, Y; Zhang, HG	1
Berbee, JK; Boekholdt, SM; Bokma, JP; Bouma, BJ; Groenink, M; Meijboom, FJ; Mulder, BJM; Post, MC; van Dijk, AP; van Melle, JP; Vliegen, HW; Winter, MM; Zwinderman, AH	1
Afarideh, M; Dehghani Firouzabadi, F; Esteghamati, A; Esteghamati, S; Ganji, M; Ghajar, A; Heidari, B; Najafi, MT; Nakhjavani, M; Noshad, S; Rabizadeh, S; Saadat, M	1

Reviews

2 review(s) available for losartan and atrial natriuretic factor

Article	Year
Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Current medical research and opinion, 2007, Volume: 23, Issue:2 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Atrial Fibrillation; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiovascular Agents; Cohort Studies; Drug Utilization; Endothelium, Vascular; Follow-Up Studies; Heart Atria; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Models, Biological; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Precursors; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Stroke; Thrombosis; Treatment Outcome	2007
Role of angiotensin II and oxidative stress in renal inflammation by hypernatremia: benefits of atrial natriuretic peptide, losartan, and tempol. Free radical research, 2015, Volume: 49, Issue:4 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic N-Oxides; Humans; Hypernatremia; Losartan; Nephritis; Oxidative Stress; Spin Labels	2015

Article

Year

Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.

Current medical research and opinion, 2007, Volume: 23, Issue:2

Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Atrial Fibrillation; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiovascular Agents; Cohort Studies; Drug Utilization; Endothelium, Vascular; Follow-Up Studies; Heart Atria; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Models, Biological; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Precursors; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Stroke; Thrombosis; Treatment Outcome

2007

Role of angiotensin II and oxidative stress in renal inflammation by hypernatremia: benefits of atrial natriuretic peptide, losartan, and tempol.

Free radical research, 2015, Volume: 49, Issue:4

Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic N-Oxides; Humans; Hypernatremia; Losartan; Nephritis; Oxidative Stress; Spin Labels

2015

Trials

10 trial(s) available for losartan and atrial natriuretic factor

Article	Year
Effects of angiotensin II receptor blockade on N-terminal proatrial natriuretic factor plasma levels in chronic heart failure. Journal of cardiac failure, 1997, Volume: 3, Issue:2 Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Biphenyl Compounds; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Losartan; Male; Middle Aged; Protein Precursors; Tetrazoles	1997
Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers. Journal of hypertension, 1998, Volume: 16, Issue:2 Topics: Adult; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Diuresis; Double-Blind Method; Enalapril; Humans; Infusions, Intravenous; Losartan; Natriuresis; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation	1998
Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. Circulation, 1999, Jun-15, Volume: 99, Issue:23 Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Cross-Over Studies; Enalapril; Female; Fibrinolysis; Heart Failure; Heart Rate; Hemodynamics; Humans; Losartan; Male; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Single-Blind Method; Tissue Plasminogen Activator; Ventricular Dysfunction, Left	1999
Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly. European journal of heart failure, 1999, Volume: 1, Issue:4 Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Chronic Disease; Double-Blind Method; Exercise Test; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Losartan; Male; Neurotransmitter Agents; Norepinephrine; Renin	1999
Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure. Clinical science (London, England : 1979), 2004, Volume: 106, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bosentan; Cardiac Output; Cardiac Output, Low; Cardiac Pacing, Artificial; Cyclic GMP; Endothelin Receptor Antagonists; Endothelin-1; Female; Infusions, Parenteral; Losartan; Natriuretic Peptide, Brain; Renin; Sheep; Sulfonamides	2004
Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy. Journal of hypertension, 2005, Volume: 23, Issue:5 Topics: Aged; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments	2005
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy. International journal of cardiology, 2006, Oct-10, Volume: 112, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left	2006
Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor. Scandinavian journal of clinical and laboratory investigation, 2008, Volume: 68, Issue:1 Topics: Adult; Aldosterone; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Cyclic GMP; Diuresis; Diuretics; Glomerular Filtration Rate; Heart Rate; Hematocrit; Humans; Indomethacin; Kidney; Kidney Function Tests; Lithium; Losartan; Male; Natriuresis; Peptide Fragments; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Receptors, Angiotensin; Renal Plasma Flow, Effective; Renin; Single-Blind Method	2008
Effect of Losartan on Right Ventricular Dysfunction: Results From the Double-Blind, Randomized REDEFINE Trial (Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-Angiotensin-Aldosterone System) in Adults With Repaired Tetralogy Circulation, 2018, 04-03, Volume: 137, Issue:14 Topics: Adult; Atrial Natriuretic Factor; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Female; Humans; Losartan; Male; Middle Aged; Placebo Effect; Prospective Studies; Protein Precursors; Tetralogy of Fallot; Treatment Outcome; Ventricular Dysfunction, Right	2018
Beneficial Effects of Pentoxifylline Plus Losartan Dual Therapy in Type 2 Diabetes with Nephropathy. The American journal of the medical sciences, 2018, Volume: 355, Issue:5 Topics: Atrial Natriuretic Factor; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Losartan; Male; Middle Aged; Pentoxifylline; Protein Precursors; Serum Albumin, Human; Treatment Outcome	2018

Other Studies

49 other study(ies) available for losartan and atrial natriuretic factor

Article	Year
[New antihypertensive drugs on various phases of study]. Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50 Suppl Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amino Acids; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Biphenyl Compounds; Diuretics; Humans; Imidazoles; Losartan; Peptides, Cyclic; Receptors, Cell Surface; Receptors, Endothelin; Sulfhydryl Compounds; Tetrazoles	1992
Chronic captopril and losartan (DuP 753) administration in rats with high-output heart failure. The American journal of physiology, 1992, Volume: 263, Issue:3 Pt 2 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Body Fluids; Captopril; Cardiac Output, High; Cardiomegaly; Hemodynamics; Homeostasis; Imidazoles; Losartan; Male; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles; Time Factors	1992
ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. The American journal of physiology, 1994, Volume: 266, Issue:6 Pt 2 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Atrial Natriuretic Factor; Biphenyl Compounds; Captopril; Cardiomegaly; Constriction; Gene Expression; Heart Ventricles; Hemodynamics; Hypertension; Imidazoles; Losartan; Mice; Mice, Inbred C57BL; Tetrazoles	1994
Cardiac hypertrophy and brain natriuretic peptide in experimental hypertension. The American journal of physiology, 1994, Volume: 266, Issue:2 Pt 2 Topics: Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Blood Urea Nitrogen; Cardiomegaly; Chromatography, High Pressure Liquid; Creatinine; Desoxycorticosterone; Enalapril; Heart; Hydralazine; Hypertension, Malignant; Imidazoles; Losartan; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred SHR; Sodium, Dietary; Tetrazoles	1994
Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension (Dallas, Tex. : 1979), 1994, Volume: 23, Issue:5 Topics: Angiotensin II; Animals; Aortic Coarctation; Atrial Natriuretic Factor; Biphenyl Compounds; Cardiomegaly; Gene Expression Regulation; Imidazoles; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles; Transforming Growth Factor beta	1994
Losartan improves the natriuretic response to ANF in rats with high-output heart failure. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:1 Topics: Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Cyclic GMP; Drug Interactions; Heart Failure; Imidazoles; Kidney; Losartan; Male; Natriuresis; Rats; Rats, Wistar; Renin-Angiotensin System; Sodium; Tetrazoles	1994
Endogenous angiotensin II modulates the effect of atrial natriuretic peptide on extracellular fluid partition. The American journal of physiology, 1993, Volume: 264, Issue:4 Pt 2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Captopril; Enalaprilat; Extracellular Space; Hematocrit; Imidazoles; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles	1993
Cellular mechanism of angiotensin II-induced atrial natriuretic peptide release in rat right atrial tissue. Life sciences, 1996, Volume: 58, Issue:19 Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Calcium; Chromatography, Ion Exchange; Heart Atria; Imidazoles; In Vitro Techniques; Losartan; Protein Kinase C; Rats; Rats, Sprague-Dawley; Tetrazoles	1996
Cyclic adenosine 3',5'-monophosphate-independent regulation of cytosolic calcium in Sertoli cells. Endocrinology, 1996, Volume: 137, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Calcium; Calcium Channel Blockers; Cyclic AMP; Cytosol; Dinoprost; Enzyme Inhibitors; Imidazoles; Isoquinolines; Kinetics; Losartan; Male; Protein Kinase C; Pyridines; Rats; Rats, Wistar; Sertoli Cells; Sulfonamides; Terpenes; Tetrazoles; Thapsigargin; Vasopressins	1996
Expression of type II cGMP-dependent protein kinase in rat kidney is regulated by dehydration and correlated with renin gene expression. The Journal of clinical investigation, 1996, Aug-01, Volume: 98, Issue:3 Topics: Animals; Atrial Natriuretic Factor; Base Sequence; Biphenyl Compounds; Chlorides; Cyclic GMP-Dependent Protein Kinases; Dehydration; Gene Expression Regulation, Enzymologic; Imidazoles; Isoenzymes; Kidney; Losartan; Male; Molecular Sequence Data; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles	1996
Effect of luminal angiotensin II and ANP on early and late cortical distal tubule HCO3- reabsorption. The American journal of physiology, 1996, Volume: 271, Issue:5 Pt 2 Topics: Absorption; Amiloride; Angiotensin II; Animals; Anti-Bacterial Agents; Atrial Natriuretic Factor; Bicarbonates; Biphenyl Compounds; Enzyme Inhibitors; Imidazoles; Kidney Cortex; Kidney Tubules, Distal; Losartan; Macrolides; Male; Rats; Rats, Wistar; Tetrazoles	1996
Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release. Circulation research, 1997, Volume: 80, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Function, Right; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Volume; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hemodynamics; Hormones; Imidazoles; Losartan; Male; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptides, Cyclic; Plasma Substitutes; Pressure; Protein Precursors; Rats; Rats, Sprague-Dawley; Sulfonamides; Tetrazoles	1997
Renal resistance to ANF in salt-depleted rats is independent of sympathetic or ANG-aldosterone systems. The American journal of physiology, 1997, Volume: 272, Issue:4 Pt 2 Topics: Adrenalectomy; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Denervation; Diet, Sodium-Restricted; Diuresis; Drug Resistance; Electrolytes; Furosemide; Glomerular Filtration Rate; Imidazoles; Kidney; Losartan; Male; Natriuresis; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reference Values; Sympathectomy, Chemical; Sympathetic Nervous System; Tetrazoles; Time Factors	1997
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats. Journal of hypertension, 1998, Volume: 16, Issue:12 Pt 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Carbazoles; Carvedilol; Heart Function Tests; Hydralazine; Hypertension; Isoquinolines; Losartan; Norepinephrine; Propanolamines; Quinapril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrahydroisoquinolines	1998
Salt-sensitive hypertension in ANP knockout mice is prevented by AT1 receptor antagonist losartan. The American journal of physiology, 1999, Volume: 277, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Hypertension; Losartan; Mice; Mice, Knockout; Sodium Chloride, Dietary	1999
Losartan reduces the vasorelaxant effect of atrial natriuretic peptide on basal tone in aorta. Clinical and experimental hypertension (New York, N.Y. : 1993), 1999, Volume: 21, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Atrial Natriuretic Factor; Calcium; Female; Imidazoles; In Vitro Techniques; Intracellular Fluid; Isotonic Solutions; Losartan; Male; Muscle, Smooth, Vascular; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vascular Resistance; Vasodilation	1999
Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats. Journal of hypertension, 1999, Volume: 17, Issue:11 Topics: Adrenomedullin; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Enalapril; Gene Expression; Heart; Hypertension; Losartan; Male; Natriuretic Peptide, Brain; Peptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reference Values	1999
Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proceedings of the National Academy of Sciences of the United States of America, 2000, Jan-18, Volume: 97, Issue:2 Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Binding, Competitive; Blotting, Northern; Cardiomegaly; Gene Expression Regulation; Heart Atria; Heart Ventricles; Humans; Imidazoles; Immunohistochemistry; Losartan; Mice; Mice, Transgenic; Myocardium; Phenotype; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tissue Distribution; Transgenes; Ventricular Remodeling	2000
Role of angiotensin II AT1 and AT2 subtype receptors in the regulation of atrial natriuretic peptide expression in salt-restricted rats. Basic research in cardiology, 2000, Volume: 95, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Imidazoles; Losartan; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium Chloride	2000
Increased central AT(1)-receptor activation, not systemic vasopressin, sustains hypertension in ANP knockout mice. American journal of physiology. Regulatory, integrative and comparative physiology, 2000, Volume: 278, Issue:6 Topics: Angiotensin II; Animals; Antihypertensive Agents; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Female; Hormone Antagonists; Hypertension; Injections, Intravenous; Losartan; Male; Mice; Mice, Knockout; Paraventricular Hypothalamic Nucleus; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasopressins	2000
Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats. Heart and vessels, 1999, Volume: 14, Issue:6 Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Calcineurin Inhibitors; Calcium; Cardiomegaly; Cell Division; Cells, Cultured; Cyclosporine; DNA; Fibroblasts; Fura-2; Hyperplasia; Losartan; Myocardium; Protein Kinase C; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Signal Transduction	1999
Interaction of angiotensin II and atrial natriuretic peptide on pH(i) regulation in MDCK cells. American journal of physiology. Renal physiology, 2000, Volume: 279, Issue:5 Topics: Acid-Base Equilibrium; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Calcium; Cell Line; Chelating Agents; Dogs; Epithelial Cells; Hydrogen-Ion Concentration; Intracellular Fluid; Kidney; Losartan; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium; Sodium-Hydrogen Exchangers	2000
Effects of angiotensin II and the AT(1) receptor antagonist losartan on the renal excretion of urodilatin. Kidney & blood pressure research, 2001, Volume: 24, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Endothelin-1; Glomerular Filtration Rate; Kidney; Losartan; Male; Peptide Fragments; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Sodium; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents	2001
Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation, 2002, Feb-12, Volume: 105, Issue:6 Topics: Aldosterone; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Factor; Body Weight; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Collagen Type III; Cyclosporine; Enzyme Inhibitors; Fibrosis; Heart; Immunosuppressive Agents; Losartan; Male; Mineralocorticoids; Myocardium; Nephrectomy; Organ Size; Rats; Rats, Inbred WKY; RNA, Messenger; Sodium Chloride, Dietary; Tacrolimus	2002
Chronic beneficial effects of type 1 angiotensin II receptor antagonist in patients with chronic hypoxemic pulmonary diseases. Cardiology, 2002, Volume: 97, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Natriuretic Factor; Female; Humans; Losartan; Lung Diseases, Obstructive; Male; Middle Aged; Natriuretic Peptide, Brain	2002
Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system. Journal of hypertension, 1996, Volume: 14, Issue:1 Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Body Water; Cardiomegaly; Cardiovascular Diseases; Disease Models, Animal; Drinking; Drug Antagonism; Heart; Hypertension; Kidney; Losartan; Male; Natriuresis; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Time Factors	1996
N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism. Journal of cardiovascular pharmacology, 2002, Volume: 40, Issue:3 Topics: Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Enzyme Inhibitors; Gene Expression Regulation; Hypertension; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin	2002
Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure. Heart and vessels, 2002, Volume: 17, Issue:2 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Creatinine; Echocardiography; Female; Heart; Heart Failure; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Potassium; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Angiotensin; Renin; Severity of Illness Index; Statistics as Topic; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left	2002
AT1 receptor blockade improves vasorelaxation in experimental renal failure. Hypertension (Dallas, Tex. : 1979), 2003, Volume: 41, Issue:6 Topics: Angiotensin Receptor Antagonists; Animals; Aorta; Atrial Natriuretic Factor; Blood Pressure; Endothelium, Vascular; Heart Ventricles; In Vitro Techniques; Losartan; Male; Mesenteric Arteries; Natriuretic Peptide, Brain; Nephrectomy; Peptidyl-Dipeptidase A; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Insufficiency; RNA, Messenger; Vasoconstriction; Vasodilation	2003
Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart. Circulation, 2003, Nov-11, Volume: 108, Issue:19 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Hypertrophic; Fibroblast Growth Factor 1; Gene Expression Regulation; Genes, fos; Heart Rate; Hypertension; Imidazoles; Infusion Pumps, Implantable; Losartan; Male; Natriuretic Peptide, Brain; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; RNA, Messenger; Vascular Endothelial Growth Factor A	2003
[Prognostic value of elevation of plasma concentration of atrial natriuretic peptide in patients with cardiac failure. Results of a cohort study]. Klinicheskaia meditsina, 2003, Volume: 81, Issue:11 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Factor; Drug Therapy, Combination; Echocardiography, Doppler; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Prognosis; Radioimmunoassay; Regression Analysis; Risk; Time Factors	2003
Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2004, Volume: 5, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Natriuretic Factor; Brain; Cyclic GMP; Diuresis; Injections, Intraventricular; Losartan; Male; Natriuresis; Neurotransmitter Agents; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Atrial Natriuretic Factor; Renin; Time Factors	2004
Effects of pre-, peri-, and postmyocardial infarction treatment with losartan in rats: effect of dose on survival, ventricular arrhythmias, function, and remodeling. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:4 Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Natriuretic Factor; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiac Volume; Dose-Response Relationship, Drug; Echocardiography; Glucose Transporter Type 4; Incidence; Losartan; Male; Monosaccharide Transport Proteins; Muscle Proteins; Myocardial Infarction; Myosin Heavy Chains; Polymerase Chain Reaction; Rats; Rats, Wistar; RNA, Messenger; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Pressure; Ventricular Remodeling	2005
Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:6 Topics: Action Potentials; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Antihypertensive Agents; Atrial Fibrillation; Atrial Natriuretic Factor; Cell Enlargement; Cell Shape; Cell Size; Cells, Cultured; Gene Expression; Heart Atria; Hypertension; Kinetics; Kv1.5 Potassium Channel; Losartan; Mechanotransduction, Cellular; Myocytes, Cardiac; Potassium; Potassium Channels, Inwardly Rectifying; Potassium Channels, Voltage-Gated; Rats; RNA, Messenger; Shal Potassium Channels	2007
Regulation of ACE2 in cardiac myocytes and fibroblasts. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 295, Issue:6 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Animals, Newborn; Atrial Natriuretic Factor; Butadienes; Cells, Cultured; Endothelin-1; Fibroblasts; Flavonoids; Gene Expression Regulation, Enzymologic; Heart Ventricles; Losartan; Mitogen-Activated Protein Kinase 1; Myocytes, Cardiac; Nitriles; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction	2008
Cardiac secretion of atrial and brain natriuretic peptides in acute ischaemic heart failure in pigs: effect of angiotensin II receptor antagonism. Clinical physiology (Oxford, England), 1997, Volume: 17, Issue:4 Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Biomarkers; Disease Models, Animal; Embolism; Female; Heart; Heart Failure; Losartan; Male; Microspheres; Myocardial Ischemia; Myocardium; Natriuretic Peptide, Brain; Protein Precursors; Swine	1997
Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition. Journal of cardiovascular pharmacology, 2010, Volume: 55, Issue:4 Topics: Angiotensin II; Animals; Antibodies; Atrial Natriuretic Factor; Cell Enlargement; Cell Line, Transformed; Cell Proliferation; Cell Survival; Curcumin; Gene Expression; Losartan; Membrane Glycoproteins; Mice; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Natriuretic Peptide, Brain; NF-kappa B; Oxidative Stress; Protein Subunits; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Scavenger Receptors, Class E; Signal Transduction; Transfection	2010
Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice. Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:12 Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Echocardiography; Gene Expression; Hemodynamics; Imidazoles; Losartan; Male; Mice; Myocardium; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan	2010
Endogenous angiotensin II suppresses stretch-induced ANP secretion via AT1 receptor pathway. Peptides, 2011, Volume: 32, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Hypertrophic; Extracellular Fluid; Gene Expression; Heart Atria; Hypertension, Renal; Imidazoles; Losartan; Male; Myocardial Contraction; Peptide Fragments; Perfusion; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reflex, Stretch	2011
Caveolae are essential for angiotensin II type 1 receptor-mediated ANP secretion. Peptides, 2011, Volume: 32, Issue:7 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Natriuretic Factor; beta-Cyclodextrins; Blood Pressure; Catheterization; Caveolae; Chromatography, High Pressure Liquid; Heart Atria; Infusion Pumps; Losartan; Male; Myocardial Contraction; Myocardium; Organ Culture Techniques; Perfusion; Protein Precursors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1	2011
The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. The Journal of steroid biochemistry and molecular biology, 2012, Volume: 132, Issue:3-5 Topics: Animals; Aorta; Atrial Natriuretic Factor; Blood Pressure; Collagen Type III; Disease Models, Animal; Ergocalciferols; Fibronectins; Fibrosis; Gene Expression Regulation; Hypertrophy, Left Ventricular; Losartan; Male; Mice; Mice, Inbred C57BL; Myocardium; Tissue Inhibitor of Metalloproteinase-1; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling	2012
Angiotensin III stimulates high stretch-induced ANP secretion via angiotensin type 2 receptor. Peptides, 2013, Volume: 42 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin III; Animals; Atrial Natriuretic Factor; Dose-Response Relationship, Drug; Heart Atria; Imidazoles; In Vitro Techniques; Infusions, Intravenous; Losartan; Male; Myocardial Contraction; Perfusion; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Signal Transduction	2013
ANP and BNP responses to dehydration in the one-humped camel and effects of blocking the renin-angiotensin system. PloS one, 2013, Volume: 8, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Natriuretic Factor; Camelus; Dehydration; Losartan; Male; Myocardium; Natriuretic Peptide, Brain; Renin-Angiotensin System	2013
Angiotensin AT2 receptor agonist stimulates high stretch induced- ANP secretion via PI3K/NO/sGC/PKG/pathway. Peptides, 2013, Volume: 47 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Atrial Pressure; Cyclic GMP-Dependent Protein Kinases; Gene Expression Regulation; Guanylate Cyclase; Heart Atria; Hypertension, Renal; Imidazoles; Losartan; Male; Nitric Oxide; Oligopeptides; Peptide Fragments; Phosphatidylinositol 3-Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Tissue Culture Techniques; Vasodilator Agents	2013
Effects of acute and subchronic AT1 receptor blockade on cardiovascular, hydromineral and neuroendocrine responses in female rats. Physiology & behavior, 2013, Oct-02, Volume: 122 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterial Pressure; Atrial Natriuretic Factor; Estradiol; Female; Heart Rate; Losartan; Ovariectomy; Oxytocin; Rats; Rats, Wistar; Sodium; Vasopressins	2013
Angiotensin IV stimulates high atrial stretch-induced ANP secretion via insulin regulated aminopeptidase. Peptides, 2015, Volume: 63 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Biomechanical Phenomena; Blood Pressure; CD13 Antigens; Extracellular Fluid; Heart Atria; Insulin; Losartan; Male; Myocardial Contraction; Rats, Sprague-Dawley; Signal Transduction	2015
Inhibition of secretory activity of atrial myocytes in hypertensive rats after losartan treatment. Bulletin of experimental biology and medicine, 2015, Volume: 158, Issue:3 Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Heart; Hypertension; Losartan; Male; Myocytes, Cardiac; Natriuretic Peptides; Rats	2015
[Changes of right atrial myoendocrine cells during hypertension and after arterial pressure decrease]. Tsitologiia, 2014, Volume: 56, Issue:10 Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Golgi Apparatus; Heart Atria; Hemodynamics; Hypertension; Losartan; Male; Myocardium; Myocytes, Cardiac; Rats; Secretory Vesicles	2014
Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 42, Issue:4 Topics: Animals; Atrial Natriuretic Factor; Calcineurin; Cardiomegaly; Cell Line; Cyclin-Dependent Kinase Inhibitor p21; Heart Ventricles; Isoproterenol; Losartan; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sterigmatocystin; Ventricular Myosins	2017